Latest

Learn how lung cancer MRD ctDNA testing detects molecular residual disease, what positive and negative results mean, how it can precede recurrence on scans, and why treatment decisions still require clinical context.

Minimal Residual Disease ctDNA Test for Lung Cancer: Recurrence Monitoring, MRD, and Tumor DNA

Learn what MSI testing means in lung cancer, how MSI-H, MSS, dMMR, and pMMR results differ, how NGS, PCR, and IHC are used, and why this rare biomarker can matter for immunotherapy and hereditary evaluation.

MSI Test for Lung Cancer: Microsatellite Instability, Mismatch Repair, and Result Meaning

Learn how Napsin A IHC supports lung adenocarcinoma diagnosis, what positive granular cytoplasmic staining means, why negative results do not exclude lung cancer, and when other tumor origins must be considered.

Napsin A IHC Test for Lung Cancer: Adenocarcinoma Marker, Tumor Origin, and Positive...

Non-Small Cell Lung Cancer Biomarker Test: Driver Mutations, PD-L1, and Molecular Profile

Learn what an NSE blood test means in small cell lung cancer, why levels can be high, how hemolysis causes false elevations, and how serial NSE trends may support treatment and recurrence monitoring.

NSE Test for Lung Cancer: Small Cell Lung Cancer Marker, High Levels, and...

Understand NTRK fusion testing in lung cancer, including tumor-agnostic meaning, RNA NGS, pan-TRK IHC, positive results, negative-result limits, and next steps.

NTRK Fusion Test for Lung Cancer: Gene Fusion, Tumor-Agnostic Marker, and Molecular Meaning

Diagnostics

Home Diagnostics Page 7

Learn what an AKT1 mutation test detects, what AKT1 E17K means, how results guide advanced breast cancer treatment, and how tumor and blood testing differ.

AKT1 Mutation Test: Breast Cancer, Solid Tumors, AKT Pathway, and Mutation...

Learn what an ALK fusion test detects, how NGS, FISH, and IHC differ, what an ALK-positive lung cancer result means, and how it guides targeted therapy.

ALK Fusion Test: Gene Fusion, Lung Cancer Marker, Positive Result, and...

Learn how APC mutation testing relates to familial adenomatous polyposis, colon cancer risk, germline versus tumor variants, mosaicism, and family testing.

APC Mutation Test: Colon Cancer, Familial Adenomatous Polyposis, Variant Meaning, and...

Learn what an ASXL1 mutation test means in AML, MDS, CMML, MPNs, and clonal hematopoiesis, including prognosis, VAF, and risk interpretation.

ASXL1 Mutation Test: Myeloid Cancer, Prognosis, Mutation Status, and Risk Meaning

Learn what an ATM mutation test means for DNA repair, hereditary breast and prostate cancer risk, tumor testing, variant classification, screening, and family follow-up.

ATM Mutation Test: DNA Repair Gene, Breast Cancer Risk, Prostate Cancer...

Learn what a BCL2 rearrangement FISH test means in follicular lymphoma, how t(14;18) is interpreted, and how MYC plus BCL2 defines double-hit disease.

BCL2 Rearrangement Test: Follicular Lymphoma, Double-Hit Lymphoma, and FISH Result

BCL6 rearrangement testing uses FISH to clarify lymphoma genetics, prognosis context, and MYC/BCL2-related classification; learn what positive and negative results mean.

BCL6 Rearrangement Test: Lymphoma, Prognosis, Rearrangement Status, and FISH Result

BCR-ABL1 testing diagnoses Philadelphia chromosome-positive CML and tracks molecular response; learn PCR levels, International Scale milestones, resistance, and monitoring.

BCR-ABL1 Test: CML, Leukemia, Philadelphia Chromosome, and Molecular Monitoring

BRAF mutation testing identifies V600E and related drivers in melanoma, colon, thyroid, and lung cancer; understand methods, positive results, prognosis, and targeted therapy.

BRAF Mutation Test: V600E, Melanoma, Colon, Thyroid, Lung Cancer, and Mutation...

BRCA1 mutation testing identifies hereditary DNA-repair risk; learn pathogenic variant and VUS meaning, breast and ovarian cancer risks, family inheritance, and next steps.

BRCA1 Mutation Test: Hereditary Cancer Risk, DNA Repair, Variant Meaning, and...

Understand BRCA2 mutation testing, hereditary cancer risk, DNA repair, pathogenic variants, VUS results, germline vs tumor findings, and family testing.

BRCA2 Mutation Test: Hereditary Cancer Risk, DNA Repair, Variant Meaning, and...

Learn what a BTK mutation test means in leukemia and lymphoma, including C481 and non-C481 resistance mutations, negative results, testing methods, and treatment relevance.

BTK Mutation Test: Leukemia, Lymphoma, Drug Resistance Marker, and Mutation Meaning

Understand CALR mutation testing for essential thrombocythemia and myelofibrosis, including type 1 and type 2 variants, platelet findings, negative results, prognosis, and next steps.

CALR Mutation Test: Myeloproliferative Neoplasm, Platelets, Myelofibrosis, and Result Meaning

Learn how cancer gene mutation panels and molecular profiling work, what actionable and uncertain variants mean, how tissue and liquid biopsy differ, and when germline testing is needed.

Cancer Gene Mutation Panel: Tumor Mutations, Gene Variants, Diagnostic Meaning, and...

Understand CDK4 amplification testing in liposarcoma, including copy-number gain, MDM2 co-amplification, FISH and NGS methods, result meaning, diagnosis, and treatment relevance.

CDK4 Amplification Test: Liposarcoma, Copy Number Gain, Cancer Marker, and Tumor...

Understand CEBPA mutation testing in AML, including bZIP in-frame mutations, ELN favorable-risk classification, prognosis, germline CEBPA, and how results affect treatment planning.

CEBPA Mutation Test: AML Prognosis, Risk Stratification, Mutation Status, and Meaning

Understand CHEK2 mutation testing, breast, colon, and prostate cancer risk, pathogenic variants versus VUS results, family inheritance, cascade testing, and screening implications.

CHEK2 Mutation Test: Breast, Colon, Prostate Cancer Risk, Variant Meaning, and...

Understand DDIT3 fusion testing for myxoid liposarcoma, including FUS::DDIT3, EWSR1::DDIT3, FISH and RNA testing, positive and negative results, and diagnostic meaning.

DDIT3 Fusion Test: Myxoid Liposarcoma, Gene Fusion, and Molecular Diagnosis

Understand EGFR mutation testing in lung cancer, including exon 19 deletions, L858R, T790M, exon 20 insertions, liquid biopsy, resistance, and treatment meaning.

EGFR Mutation Test: Exon 19, L858R, T790M, Mutation Status, and Lung...

Understand EPCAM deletion testing for Lynch syndrome, including MSH2 silencing, colorectal cancer risk, MMR and MSI findings, family inheritance, and surveillance implications.

EPCAM Deletion Test: Lynch Syndrome, Colon Cancer Risk, MSH2 Silencing, and...

1...678...92 Page 7 of 92